Tus kws kho mob
P37-24 Residential Treatment Claims for Minnesota Health Care Programs
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 03, 2024
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1161 - 1170 ntawm 4139
Tus kws kho mob
bc-com-pharmprogpolicynotifctn-eff-7-15-24.pdf
Tus kws kho mob
Upcoming pharmacy policies effective July 1 2024
Tus kws kho mob
bc-mhcp-pharmprogpolicynotifctn-eff-6-1-24.pdf
Tus kws kho mob
gc-081-inappropriate-diagnosis-code-list.pdf
Tus kws kho mob
QP44-24 MHCP Pharmacy Benefit Exclusion for Anktiva® and Docivyx™
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 22, 2024
Tus kws kho mob
QP38-24 Training Webinars for New Prior Authorization Submission Process
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 22, 2024
Tus kws kho mob
QP37-24 Update for New-to-Market Medical Drugs: atidarsagene autotemcel, crovalimab, and fidanacogene eleparvovec
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 08, 2024
Tus kws kho mob
QP43-24 MHCP Pharmacy Benefit Exclusion for Alyglo™ and Lenmeldy™
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 08, 2024